Garapaty Anusha, Champion Julie A
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Dr. NW, Atlanta, Georgia 30332.
Biointerphases. 2015 Sep 15;10(3):030801. doi: 10.1116/1.4922798.
Organisms depend upon complex intercellular communication to initiate, maintain, or suppress immune responses during infection or disease. Communication occurs not only between different types of immune cells, but also between immune cells and nonimmune cells or pathogenic entities. It can occur directly at the cell-cell contact interface, or indirectly through secreted signals that bind cell surface molecules. Though secreted signals can be soluble, they can also be particulate in nature and direct communication at the cell-particle interface. Secreted extracellular vesicles are an example of native particulate communication, while viruses are examples of foreign particulates. Inspired by communication at natural immunological interfaces, biomimetic materials and designer molecules have been developed to mimic and direct the type of immune response. This review describes the ways in which native, biomimetic, and designer materials can mediate immune responses. Examples include extracellular vesicles, particles that mimic immune cells or pathogens, and hybrid designer molecules with multiple signaling functions, engineered to target and bind immune cell surface molecules. Interactions between these materials and immune cells are leading to increased understanding of natural immune communication and function, as well as development of immune therapeutics for the treatment of infection, cancer, and autoimmune disease.
生物体依靠复杂的细胞间通讯来在感染或疾病期间启动、维持或抑制免疫反应。通讯不仅发生在不同类型的免疫细胞之间,也发生在免疫细胞与非免疫细胞或致病实体之间。它可以直接在细胞-细胞接触界面发生,也可以通过结合细胞表面分子的分泌信号间接发生。虽然分泌信号可以是可溶的,但它们在本质上也可以是颗粒状的,并在细胞-颗粒界面进行直接通讯。分泌的细胞外囊泡是天然颗粒通讯的一个例子,而病毒是外来颗粒的例子。受天然免疫界面通讯的启发,人们开发了仿生材料和设计分子来模拟和引导免疫反应的类型。这篇综述描述了天然、仿生和设计材料介导免疫反应的方式。例子包括细胞外囊泡、模拟免疫细胞或病原体功能的颗粒,以及具有多种信号功能的杂交设计分子,这些分子经过工程设计以靶向并结合免疫细胞表面分子。这些材料与免疫细胞之间的相互作用正在加深我们对天然免疫通讯和功能的理解,同时也推动了用于治疗感染、癌症和自身免疫性疾病的免疫疗法的发展。